India city Hyderabad covid-19 pandemic patient India city Hyderabad

Dr Reddy's signs pact with Eli Lilly to produce Covid treatment drug in India

Reading now: 336
www.livemint.com

Eli Lilly and Company for the manufacture and commercialization of Baricitinib in India, the Hyderabad-based pharma company said on Tuesday.Baricitinib has received restricted emergency use approval from the Central Drugs Standard Control Organisation (CDSCO) for use in combination with Remdesivir.The drug is to be used in the treatment of suspected or laboratory-confirmed Covid-19 infections in hospitalised adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO)."This partnership comes at a critical juncture in the fight against the pandemic in India, and adds to the company’s existing range of Covid-19 therapeutics covering the full spectrum from mild to moderate and severe.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA